DIRECT ORAL ANTICOAGULANTS in adults with epilepsy had been related to totally different thromboembolic, bleeding, and mortality outcomes relying on the antiseizure treatment used, in line with a big retrospective cohort research.
Researchers evaluated the comparative security of generally prescribed antiseizure medicines in adults receiving direct oral anticoagulants.
Utilizing knowledge from a global digital well being document community, the staff emulated a goal trial and in contrast levetiracetam, valproate, average enzyme inducing antiseizure medicines, and robust enzyme inducing antiseizure medicines in opposition to a pooled reference group receiving lamotrigine or lacosamide.
From 2.29 million adults with epilepsy, 40,932 had been eligible for direct oral anticoagulant remedy. A complete of 9,529 remedy initiators had been included within the remaining evaluation. The imply age was 63 years, and 51% had been feminine.
Increased Thromboembolic Threat Noticed
In matched analyses, levetiracetam was related to a better threat of thromboembolic occasions in contrast with lamotrigine or lacosamide. It was additionally related to elevated all-cause mortality. Main bleeding threat was comparable between teams.
Sturdy enzyme inducing antiseizure medicines, together with carbamazepine and phenytoin, had been likewise related to increased thromboembolic threat. Nonetheless, these therapies had been linked to a decrease threat of main bleeding.
The investigators estimated that roughly 28% of thromboembolic occasions could have been preventable if outcomes had matched these noticed within the lamotrigine or lacosamide reference group.
Mortality and Bleeding Considerations with Valproate
Valproate confirmed a definite threat profile. In contrast with the reference group, valproate was related to increased all-cause mortality, in addition to a better threat of intracranial main bleeding.
Notably, amongst adults handled with vitamin Ok antagonists, thromboembolic dangers had been reported to be close to null.
The authors concluded that antiseizure treatment alternative represents a doubtlessly modifiable issue influencing outcomes in adults with epilepsy receiving direct oral anticoagulants, highlighting the significance of remedy choice when balancing thromboembolic and bleeding dangers.
Reference
Schubert KM et al. Security of Antiseizure Drugs Throughout Direct Oral Anticoagulant Remedy in Epilepsy. JAMA Neurol. 2026;DOI:10.1001/jamaneurol.2026.2712
Featured picture: mjowra on Adobe Inventory
